Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 35,951 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 35,951 shares of Alignment Healthcare stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the transaction, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This trade represents a 9.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hyong Kim also recently made the following trade(s):

• On Wednesday, March 18th, Hyong Kim sold 18,404 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total value of $328,327.36.

Alignment Healthcare Stock Performance

Shares of Alignment Healthcare stock opened at $19.78 on Tuesday. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. The business has a 50 day moving average price of $18.55 and a 200-day moving average price of $19.42. The company has a market cap of $4.09 billion, a PE ratio of 219.78, a price-to-earnings-growth ratio of 2.67 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s quarterly revenue was up 33.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. Equities analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. UBS Group upped their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Wolfe Research assumed coverage on shares of Alignment Healthcare in a research report on Friday, April 17th. They set an “outperform” rating and a $24.00 price target on the stock. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Barclays reduced their price objective on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Finally, Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $24.30.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Hudson Bay Capital Management LP bought a new position in Alignment Healthcare during the third quarter worth about $4,581,000. 1492 Capital Management LLC raised its position in shares of Alignment Healthcare by 61.8% in the fourth quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock valued at $6,416,000 after purchasing an additional 124,143 shares during the period. Cinctive Capital Management LP purchased a new stake in shares of Alignment Healthcare during the 3rd quarter valued at approximately $3,814,000. Vanguard Group Inc. lifted its stake in shares of Alignment Healthcare by 5.0% during the 3rd quarter. Vanguard Group Inc. now owns 13,968,584 shares of the company’s stock valued at $243,752,000 after buying an additional 664,769 shares in the last quarter. Finally, William Blair Investment Management LLC boosted its holdings in Alignment Healthcare by 43.4% in the 3rd quarter. William Blair Investment Management LLC now owns 2,119,952 shares of the company’s stock worth $36,993,000 after buying an additional 641,381 shares during the period. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.